Non small cell lung cancer
Conditions
Interventions
one:Hyperfraction radiotherapy
Sponsors
Beijing Luhe Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
15 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Voluntary participation and written informed consent (2) Gender is not limited, age from 18 to 75 (3) Histologically or cytologically proven NSCLC (4) Stage III or oligometastatic stage IV NSCLC (5) All patients could not tolerate or refuse the operation (6) The size of the primary lesion was limited to = 70, estimated survival > 3 months
Exclusion criteria
Exclusion criteria: (1) Patients who had received radiotherapy before enrollment (including patients who relapsed after radiotherapy); (2) Have serious comorbidities, such as hypertension, coronary heart disease, mental history or serious allergy history; (3) Refuse or fail to sign the informed consent for participating in the trial; (4) Estimated survival period <= 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DCR/ORR;Acute response to radiotherapy and chemotherapy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Local recurrence rate / disease-free survival rate / overall survival rate;Late radiotherapy response; | — |
Countries
China
Contacts
Public ContactGao Yuyan
82 Xinhua Road South, Tongzhou District, Beijing
Outcome results
None listed